[CAS NO. 1370256-78-2]  SKLB4771 (FLT3-IN-1)

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1370256-78-2]

Catalog
AS865977
Brand
Arctom Scientific
CAS
1370256-78-2

DESCRIPTION [1370256-78-2]

Overview

MDLMFCD28900746
Molecular Weight537.66
Molecular FormulaC25H27N7O3S2
SMILESO=C(NC1=CC=C(C)C=C1)NC2=NN=C(SC3=C4C=CC(OCCCN5CCOCC5)=CC4=NC=N3)S2

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM1.8599 mL9.2996 mL18.5991 mL
5 mM0.3720 mL1.8599 mL3.7198 mL
10 mM0.1860 mL0.9300 mL1.8599 mL
50 mM0.0372 mL0.1860 mL0.3720 mL

Description

SKLB4771 is a potent and selective inhibitor of human receptor-type tyrosine-protein kinase with IC50 of 10 nM.

Targets

FLT3 [1]
(Cell-free assay)
10 nM

In vitro

SKLB4771 just weakly inhibits Aurora A, FMS, FLT4, and c-Kit (IC50s: 1.5 μM, 2.8 μM, 3.7 μM, and 6.8 μM, respectively). SKLB4771 displays almost no inhibitory activity against the other 13 selected protein kinases. SKLB4771 potently inhibits the growth of MV4-11 cells that express FLT3-ITD, with an IC50 value of 0.006 μM. SKLB4771 just exhibits very weak inhibitory activity against human T lymphoma Jurkat cells, human Burkitt’s lymphoma Ramos cells, human lung cancer PC-9 and H292 cells, and human epithelial carcinoma A431 cells (IC50: 3.05 μM, 6.25 μM, 3.72 μM, 6.94 μM, and 8.91 μM, respectively)..